Author Question: ____ is a pricing goal that is impossible to achieve. A) Profit maximization B) Survival pricing ... (Read 253 times)

LaDunn

  • Hero Member
  • *****
  • Posts: 526
____ is a pricing goal that is impossible to achieve.
 A) Profit maximization
  B) Survival pricing
  C) Market-share pricing
  D) Target return on investment pricing

Question 2

Define design planning. How does it differ from operational planning?



DHRUVSHAH

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

A

Answer to Question 2

Design planning is the development of a plan for converting an idea into an actual product or service. Design planning is a bigger, overall plan of converting an idea into a reality whereas operational planning is a smaller plan that provides finer details at a more specific level of deciding on the amount of products or services each production facility will produce during a specific time period.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library